Summary for Cholera Vaccine


GeriatricPediatric
  • Trade Name: Vaxchora (PaxVax)
  • Indications: Immunization against cholera for adults traveling to cholera-affected areas
  • Class: Vaccine
  • Half-life: N/A
  • FDA Approval Date: 06/10/2016
  • Clinically important, potentially hazardous interactions with:
    Antibiotics, Chloroquine
  • Pregnancy: Not expected to cause fetal risk

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top